CHUGAI PHARMACEUTICAL CO., LTD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,782 JPY | -0.10% |
|
+2.11% | -10.46% |
| May. 23 | Tech stocks lift Japan's Nikkei on boost from Nvidia's robust outlook | RE |
| May. 14 | Japan's Nikkei drifts sideways as more earnings, US CPI awaited | RE |
Presenter SpeechToshiaki Itagaki (Executives)[Interpreted] Good evening, ladies and gentlemen....
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
4,787
JPY
Average target price
5,932
JPY
Spread / Average Target
+23.92%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.46% | 50.72B | |
| +42.83% | 748B | |
| +34.11% | 598B | |
| -5.70% | 356B | |
| +18.06% | 325B | |
| +4.63% | 283B | |
| +17.02% | 245B | |
| +9.26% | 211B | |
| -4.21% | 209B | |
| +2.43% | 166B |
- Stock Market
- Equities
- 4519 Stock
- News Chugai Pharmaceutical Co., Ltd
- Transcript : Chugai Pharmaceutical Co., Ltd., Q1 2020 Earnings Call, Apr 23, 2020
